IDEX’s (NYSE:IEX) Q2 CY2026 Sales Beat Estimates, Provides Encouraging Guidance
IDEX (NYSE:IEX) reported Q2 CY2026 revenue of $920.6 million, up 6.4% year on year and 1.7% above Wall Street estimates. Non-GAAP EPS was $2.32, up from $2.07, beating consensus by 9.9%. Management guided next-quarter revenue to a $931.4 million midpoint, and analysts expect full-year EPS to rise from $8.45 to $8.89.
How this was made
The 30-second read
Why it matters
The key tradable inputs are the Q2 revenue and adjusted EPS beats and the next-quarter revenue midpoint guidance that is above analysts’ estimates, which can drive near-term estimate revisions and sentiment.
Market read
A concrete earnings/guidance print with specific beat amounts and a higher-than-estimated revenue midpoint can move IEX’s near-term expectations and trading range.
What to watch
The guidance is for next quarter only; traders may need to watch whether margin stability (operating margin flat YoY) can hold if revenue growth continues to decelerate.
Background
IDEX is a global manufacturer of pumps, flow meters, and fluidics systems, and the article frames its Q2 CY2026 results versus Wall Street expectations.
Ticker impact
IDEX reported Q2 CY2026 revenue of $920.6M, beat estimates by 1.7%, and guided next-quarter revenue to $931.4M midpoint.
Likely supports continued upside bias versus pre-report expectations, with focus shifting to whether the guided growth rate is sustained.
The article provides specific Q2 results (revenue, adjusted EPS) and a concrete next-quarter revenue midpoint above consensus, which are direct drivers of near-term valuation and revisions.
Market effects
Signals resilience in engineered industrial demand, though the article also flags decelerating organic growth and margin drift over longer horizons.
No specific regional demand or macro linkage is provided.
No explicit global supply-chain or international regulatory developments are mentioned.
Counterpoint
Despite the beat, the article highlights slower organic growth (2.7% YoY average over two years) and underwhelming sell-side revenue growth expectations (3.5% over 12 months).
Key entities
- companyIDEX
Reported Q2 CY2026 revenue and adjusted EPS beats and provided next-quarter revenue guidance.
